Trials / Terminated
TerminatedNCT01723085
Anti-Mullerian Hormone Levels Before and After an Open Myomectomy
Anti-Mullerian Hormone Levels Variations Following an Open Myomectomy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- Clinique Ovo · Industry
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. It is well known that ovarian surgery for endometriosis lowers Anti-Mullerian hormone, but little is known for other surgeries. We seek to investigate the hormone variations before and after an open myomectomy. Hypothesis: Anti-Mullerian hormone levels drop following surgery but return to normal levels in a few months
Conditions
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2012-11-07
- Last updated
- 2018-07-30
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01723085. Inclusion in this directory is not an endorsement.